Century Therapeutics Inc Cash Flow Reinvestment Rate
Century Therapeutics Inc cash flow reinvestment rate. Century Therapeutics Inc (IPSC) has a Cash Flow Reinvestment Rate of 0.51x as of March 2022, reinvesting $44.04 Million (capex $4.07 Million plus investments $-39.97 Million) from operating cash flow of $86.75 Million. Explore Century Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Century Therapeutics Inc (2015–2022)
Cash flow reinvestment rate of Century Therapeutics Inc from 2015 to 2022. Historical reinvestment intensity for Century Therapeutics Inc across 2 annual periods. Explore capital reinvestment ratio of Century Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Century Therapeutics Inc Cash Flow Reinvestment Rate by Year (2015–2022)
Century Therapeutics Inc cash flow reinvestment rate by year from 2015 to 2022. Year-by-year capital reinvestment analysis for Century Therapeutics Inc. For the full cash flow conversion analysis, see Century Therapeutics Inc (IPSC) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 3.42x | $48.08 Million | $14.05 Million | $30.60 Million | ▲ +1114.0% |
| 2015 | 0.28x | $29.39 Million | $104.30 Million | $29.39 Million | — |